Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113369562 | 11336956 | 2 | F | 20160805 | 20150804 | 20160927 | PER | US-ASTRAZENECA-2015SE72506 | ASTRAZENECA | 0.00 | F | Y | 71.70000 | KG | 20160928 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113369562 | 11336956 | 1 | PS | BYDUREON | EXENATIDE | 1 | Subcutaneous | U | U | FN0142 | 22200 | 2 | MG | /wk | |||||
| 113369562 | 11336956 | 2 | SS | BYETTA | EXENATIDE | 1 | Unknown | 0 | SOLUTION FOR INJECTION IN PRE-FILLED PEN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113369562 | 11336956 | 1 | Diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113369562 | 11336956 | Injection site extravasation | |
| 113369562 | 11336956 | Injection site haemorrhage | |
| 113369562 | 11336956 | Injection site pain | |
| 113369562 | 11336956 | Intentional product misuse | |
| 113369562 | 11336956 | Product quality issue | |
| 113369562 | 11336956 | Skin discolouration | |
| 113369562 | 11336956 | Underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |